Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
COV > SEC Filings for COV > Form 8-K on 22-Jul-2014All Recent SEC Filings

Show all filings for COVIDIEN PLC



Change in Directors or Principal Officers, Regulation FD Disclosure, Financial State

Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(e) Compensatory Arrangements of Certain Officers

On July 16, 2014, the Compensation and Human Resources Committee of the Board of Directors of Covidien plc ("Covidien") approved an increase in Bryan Hanson's base salary from $607,400 to $702,000 and an increase in his total bonus opportunity from 85% to 90% in connection with Mr. Hanson's assumption of the role of Group President, Covidien. Mr. Hanson will assume his new role, and the increase in his compensation will take effect, at the beginning of Covidien's fiscal year 2015.

Item 7.01. Regulation FD Disclosure.

Covidien today issued a press release announcing that Bryan Hanson, Group President, Medical Devices & U.S., will be elevated to the newly created position of Group President, Covidien, effective October 1, 2014. In this role, Mr. Hanson will have global responsibility for all Covidien business segments. Mr. Hanson has overseen the company's Surgical Solutions, Vascular Therapies and Respiratory & Monitoring Solutions business units, as well as its Health Systems organization, since October 2013. He recently assumed oversight of the company's Emerging Markets business and will add responsibility for the company's Developed Markets and Medical Supplies businesses when his appointment becomes effective.

A copy of the press release is furnished as Exhibit 99.1 to this report.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

99.1 Press Release dated July 22, 2014

  Add COV to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for COV - All Recent SEC Filings
Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.